Display Settings:

Format

Send to:

Choose Destination
Am J Clin Nutr. 2014 May;99(5):999-1005. doi: 10.3945/ajcn.113.071399. Epub 2014 Feb 26.

Obesity paradox in cancer: new insights provided by body composition.

Author information

  • 1Postgraduation Program on Health and Behavior, Catholic University of Pelotas, Pelotas, Brazil (MCG); the Nutrition College of Nutrition, Federal University of Pelotas, Pelotas, Brazil (CAP and SPO); the Pennington Biomedical Research Center, Baton Rouge, LA (SBH and MCG); and the Study Group on Body Composition and Nutrition, COCONUT (MCG, CAP, and SPO).

Abstract

BACKGROUND:

Obesity, defined by body mass index (BMI), appears to have a paradoxical protective effect in several chronic diseases.

OBJECTIVE:

We investigated the obesity paradox in cancer patients by using body composition.

DESIGN:

The study was an observational study of 175 cancer patients assessed before chemotherapy. Obesity was defined as BMI (in kg/m(2)) ≥30 or fat mass index (FMI; fat mass divided by the square of height) ≥5.2 (men) and ≥8.2 (women) measured by using a bioelectrical impedance analysis. Low muscle mass (sarcopenia) was defined as fat-free mass index (fat-free mass divided by the square of height) <17.5 (men) and <15.1 (women).

RESULTS:

Most patients were women (65.7%) and had a mean (±SD) age of 56.9 ± 12.8 y. According to BMI criteria, 60% of patients were overweight or obese. The median survival time for overweight (2.64 y; range: 0.23-3.16 y) and obese (2.61 y; range: 0.26-3.20 y) patients was significantly higher than for patients with a normal (2.04 y; range: 0.06-3.05 y) or low (0.52 y; range: 0.19-0.98 y) BMI (P < 0.001). Sarcopenic patients had shorter survival, regardless of their FMI. Obesity predicted higher survival rates only when sarcopenia was absent. In a multivariate Cox regression model, sarcopenia was an independent predictor of higher mortality (HR: 5.19; 95% CI: 2.58, 10.43) after we controlled for BMI, age, and tumor stage.

CONCLUSIONS:

The obesity paradox is present in cancer patients only when obesity is defined by BMI. Patients with sarcopenic obesity had the poorest prognosis. Cancer patients with high mortality risk can be identified by a body-composition assessment.

Comment in

PMID:
24572565
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk